Results

Total Results: 110 records

Showing results for "indication".
Users also searched for: medication reconciliation

  1. cds.ahrq.gov/sites/default/files/workgroups/1131/CDS%20Connect%20Work%20Group%20March%202020%20Meeting%20Slides.pdf
    March 01, 2020 - FHIR and CCL Call, MSH FHIR and UX Display • Clear indication that this dynamic calculator does NOT
  2. cds.ahrq.gov/cedar/AHRQ_CEDAR_Contribution_Agreement_508.pdf
    September 28, 2022 - AHRQ CEDAR Contribution Agreement Contributing Thank you for your interest in contributing to the open source CEDAR project! We welcome all friendly contributions, including: • bug reports • comments and suggestions • feature requests • bug fixes • feature implementations and enhancements • documentation …
  3. cds.ahrq.gov/sites/default/files/workgroups/1251/CDS_Connect_WG_Jan2021_Summary.pdf
    January 21, 2021 - CDS Connect Work Group Meeting Summary 1-21-2021 CDS (Clinical Decision Support) Connect Work Group Meeting Summary January 21, 2021 3:00 – 4:00 pm ET Attendees: 52 people (48 attendees + 4 call-ins) Organization Attendee Names AHRQ Members Steve Bernstein, Roland Gamache, Ed Lomotan, Mario Terán (…
  4. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/hook.json
    January 01, 2023 - { "hook": "patient-view", "title": "CTPA order check", "description": "CTPA order check cds hook", "id": "pe", "prefetch": { "patient": "Patient/{{context.patientId}}", "wells": "Observation?subject={{context.patientId}}&code=http://loinc.org|89547-4", "ddimer": "Observation?subject={{cont…
  5. cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Pilot_Report_October_2022_508.pdf
    January 01, 2022 - AHRQ CEDAR Final Pilot Report AHRQ CEDAR Final Pilot Report Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Modernize Healthcare (The Health FFRDC) A Federally Funded Research and Development Center …
  6. cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation%20Guide_Healthful%20Diet%20and%20Physical%20Activity_Final.pdf
    September 01, 2019 - or more abnormal lab result value(s), since abnormal lab results alone may not provide an accurate indication … A result of >130 mg/dL is an indication of dyslipidemia. … A result of <40 mg/dL is an indication of dyslipidemia.
  7. cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Title of document or resource Repository Work Group Meeting Summary Date 03/08/2017 Time 1:30 – 3:30 PM ET AGENDA · Clarify Details Related to Existing Artifacts · Logic exclusions, specification of conditions, lookback periods and the inclusion of parameters for scalar values · Considerations for art…
  8. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
    October 17, 2018 - Either there is an indication that the recommended dosing sequence was not followed (i.e., there is … populated, then the evaluators marked that entry in the form shown in Appendix A.1 with a “1” as an indication
  9. cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 04/19/2017 Time 01:00 – 3:00 PM EST AGENDA · Welcome · Brief Overview of Existing CDS Connect Artifacts · Clarify Logic Details for USPTF-related Artifacts · Discuss Best Approach for Transforming eCQM Specifications into CDS Logic · Next Steps an…
  10. cds.ahrq.gov/sites/default/files/workgroups/1176/CDS%20Connect%20Work%20Group%20May%202020%20Meeting%20Slides.pdf
    May 01, 2020 - May 2020 CDS Connect Work Group Call May 2020 CDS Connect Work Group Call Agenda Schedule Topic • 3:00 – 3:02 • Roll Call, Michelle Lenox (MITRE) • 3:02 – 3:05 • Review of the Agenda, Maria Michaels (CDC) • 3:05 – 3:50 • CDS Artifact Review and Update across CDS Connect (MITRE) • 3:50– 3:55 • What's New with …
  11. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - delaying progression to diabetes in certain populations but has not secured FDA approval for this indication
  12. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_CDS_Connect_IG_T2DM_Part_Two_Counseling_0.pdf
    January 01, 2023 - delaying progression to diabetes in certain 19 populations but has not secured FDA approval for this indication
  13. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/CQL%20to%20CDS%20Hooks%20cards_0.txt
    January 01, 2023 - Mapping of CQL conditions to CDS Hooks cards Condition: NoDDimerNoWells Card: It is recommended to assess the patient's risk for pulmonary embolism (PE) and evaluate D-dimer levels before proceeding with a CTPA order. Use the following link to evaluate the risk. Launch Questionnaire: Yes Condition: NoDDimerWellsLessT…
  14. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Cholesterol Management Work Group recommendation based on their medical expertise), and active dialysis is an indication
  15. cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20Two%20Counseling_Final.pdf
    September 01, 2019 - Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling 1 Implementation Guide Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. HHSA29…
  16. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - If there is an indication that the patient cannot tolerate a particular recommended treatment, an
  17. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - CDS Connect Implementation Guide Draft Agency for Healthcare Research and Quality (AHRQ) Agency for Healthcare Research and Quality (AHRQ) Implementation Guide Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Hu…
  18. cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - A result of >130 mg/dL is an indication of dyslipidemia. … A result of <40 mg/dL is an indication of dyslipidemia.
  19. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - A result of >130 mg/dL is an indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of dyslipidemia, a risk factor for developing CAD and stroke.
  20. cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide%20Abnormal%20Blood%20Glucose%20and%20Type%202%20DM%20Counseling.pdf
    September 01, 2021 - Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling 1 Implementation Guide Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: